This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Buchanan, D. Articles by Muirhead, K. Search for Related Content PubMed PubMed Citation Articles by Buchanan, D. Articles by Muirhead, K. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Nausea and Vomiting Social Bookmarking                         What's this?

Letter to the editor: Use Intractable nausea and vomiting successfully related with granisetron 5-hydroxtrytamine type 3 receptor antagonists in Palliative Medicine

SPR in Palliative Medicine Roxburghe House NHS Tayside Dundee, deansbuchanan{at}nhs.net

Kirsty Muirhead

Consultant in Palliative Medicine The Ayrshire Hospice, Ayrshire

References

• Tong JG Selective Serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same? CNS Drugs 2005; 19: 225—38 .
• Currow DC, Coughlan M., Fardell B., Cooney NJ Use of ondansetron in palliative medicine . J Pain Symptom Manag 1997; 13(5): 302—7 .[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Cole RM, Robinson F., Harvey L., Trethowan K., Murdoch V. Successful control of intractable nausea and vomiting requiring combined ondansetron and haloperidol in a patient with advanced cancer . J Pain Symptom Manag 1994; 9(1): 48—50 .[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Corrigan BW, Nicholls B., Thakrar B., Lam R., Grosse C., Alianti J. et al. Heterogeneity in systemic availability of ondansetron and granisetron following oral administration . Drug Metab Dispos 1999; 27(1): 110—2 .[Abstract/Free Full Text]
• Kaiser R., Sezer O., Papies A., Bauer S., Schelenz C., Tremblay P-B. et al. Patient-tailored antiemetic treatment with 5-Hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes . J Clin Oncol 2002; 20(12): 2805—11 .[Abstract/Free Full Text]
• Dickman A., Schneider J., Varga J. The Syringe Driver, Continuous subcutaneous infusions in palliative care. Second edition. Oxford University Press , 2005.

Palliative Medicine, Vol. 21, No. 8, 725-726 (2007)
DOI: 10.1177/0269216307083383


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Buchanan, D. Articles by Muirhead, K. Search for Related Content PubMed PubMed Citation Articles by Buchanan, D. Articles by Muirhead, K. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Nausea and Vomiting Social Bookmarking                         What's this?